How It Works
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino acid analog of IGF-1 with a 13-amino acid extension at the N-terminus and an arginine substitution at position 3. These modifications give it a dramatically longer half-life (~20-30 hours vs 15 minutes for native IGF-1) and reduce binding to IGF binding proteins, keeping more active IGF-1 in circulation.
Common Research Protocols
Research Dosing Range
20–50 mcg subcutaneously or intramuscularly once daily. Often administered post-workout for maximum effect. Cycles are typically short: 4–6 weeks maximum, followed by equal time off. Some protocols use bilateral intramuscular injection in target muscle groups. This is a powerful compound — careful monitoring is essential.
Use our free dosing calculator to determine exact syringe units after reconstitution.
Reconstitution Guide
Follow these steps to properly reconstitute IGF-1 LR3 for research use:
- Step 1: Swab the tops of both the peptide vial and bacteriostatic water vial with alcohol.
- Step 2: Draw your desired amount of BAC water (commonly 1–2 mL) into an insulin syringe.
- Step 3: Inject the water slowly into the peptide vial, aiming at the glass wall — not directly onto the powder.
- Step 4: Swirl the vial gently until fully dissolved — never shake.
- Step 5: Refrigerate at 36–46°F (2–8°C). Use within 4–6 weeks.
Use the dosing calculator to calculate your exact concentration (mcg per unit) and how many units to draw on your syringe.
Frequently Asked Questions
How does IGF-1 LR3 work? ▾
IGF-1 LR3 (Long R3 Insulin-like Growth Factor-1) is an 83-amino acid analog of IGF-1 with a 13-amino acid extension at the N-terminus and an arginine substitution at position 3. These modifications give it a dramatically longer half-life (~20-30 hours vs 15 minutes for native IGF-1) and reduce binding to IGF binding proteins, keeping more active IGF-1 in circulation.
What are the key research findings? ▾
- Promotes muscle hyperplasia — the creation of new muscle cells, not just larger ones
- 3x more potent than native IGF-1 due to reduced binding protein interaction
- Enhances nutrient shuttling, protein synthesis, and nitrogen retention
- May improve fat metabolism through direct lipid oxidation effects
What is the typical dosing protocol? ▾
20–50 mcg subcutaneously or intramuscularly once daily. Often administered post-workout for maximum effect. Cycles are typically short: 4–6 weeks maximum, followed by equal time off. Some protocols use bilateral intramuscular injection in target muscle groups. This is a powerful compound — careful monitoring is essential.
How should IGF-1 LR3 be stored? ▾
Unreconstituted powder should be stored in a freezer or refrigerator away from light and moisture. Once reconstituted with bacteriostatic water, refrigerate at 36–46°F (2–8°C) and use within 4–6 weeks. Never freeze reconstituted peptides.